Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KD018 with Chemo-Radiation in Rectal Cancer
NCT02178644Phase 1Completed
- Sponsor
- Yale University
- Start
- Jul 2014
- Primary completion
- Sep 2019
- Modality
- Botanical Extract
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of PHY906 in gastrointestinal toxicity, sponsored by Yale University. Primary endpoint: Grade 3-4 Toxicity Rate up to 10 Months. Started Jul 2014; status: completed.
02
Drugs
PHY906
03
Conditions
gastrointestinal toxicity
Beyond the preview
Go deeper on NCT02178644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02178644.